BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15154833)

  • 21. Increasing the number of diagnostic mutations in malignant hyperthermia.
    Levano S; Vukcevic M; Singer M; Matter A; Treves S; Urwyler A; Girard T
    Hum Mutat; 2009 Apr; 30(4):590-8. PubMed ID: 19191329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of the Lys(3614)-Asn(3643) calmodulin-binding domain with the Cys(4114)-Asn(4142) region of the type 1 ryanodine receptor is involved in the mechanism of Ca2+/agonist-induced channel activation.
    Gangopadhyay JP; Ikemoto N
    Biochem J; 2008 Apr; 411(2):415-23. PubMed ID: 18171325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal ryanodine receptor function in heart failure.
    Yano M; Yamamoto T; Ikemoto N; Matsuzaki M
    Pharmacol Ther; 2005 Sep; 107(3):377-91. PubMed ID: 15951021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defective Mg2+ regulation of RyR1 as a causal factor in malignant hyperthermia.
    Steele DS; Duke AM
    Arch Biochem Biophys; 2007 Feb; 458(1):57-64. PubMed ID: 16620769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sarcoplasmic reticulum Ca2+ refilling controls recovery from Ca2+-induced Ca2+ release refractoriness in heart muscle.
    Szentesi P; Pignier C; Egger M; Kranias EG; Niggli E
    Circ Res; 2004 Oct; 95(8):807-13. PubMed ID: 15388639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redox regulation of cardiac calcium channels and transporters.
    Zima AV; Blatter LA
    Cardiovasc Res; 2006 Jul; 71(2):310-21. PubMed ID: 16581043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia.
    Aleman M; Riehl J; Aldridge BM; Lecouteur RA; Stott JL; Pessah IN
    Muscle Nerve; 2004 Sep; 30(3):356-65. PubMed ID: 15318347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Advances in research of malignant hyperthermia].
    Takagi A; Kojima S
    Nihon Rinsho; 1990 Jul; 48(7):1557-62. PubMed ID: 2169543
    [No Abstract]   [Full Text] [Related]  

  • 29. A SNO storm in skeletal muscle.
    Stamler JS; Sun QA; Hess DT
    Cell; 2008 Apr; 133(1):33-5. PubMed ID: 18394987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant hyperthermia may be due to a defect in a large Ca2+ release channel protein.
    Davies K
    Trends Genet; 1990 Jun; 6(6):171-2. PubMed ID: 2164719
    [No Abstract]   [Full Text] [Related]  

  • 31. Calcium transporters and their role in the development of neuronal disease and neuronal damage.
    Jaskova K; Pavlovicova M; Jurkovicova D
    Gen Physiol Biophys; 2012 Dec; 31(4):375-82. PubMed ID: 23255663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sarcoplasmic reticulum calcium uptake in cryostat sections of skeletal muscle from malignant hyperthermia patients and controls.
    Allen PD; Ryan JF; Jones DE; Mabuchi K; Virga A; Roberts J; Sreter F
    Muscle Nerve; 1986 Jun; 9(5):474-5. PubMed ID: 3724793
    [No Abstract]   [Full Text] [Related]  

  • 33. Ryanodine receptor-2: a necessity for gating store-operated Ca2+ channels.
    Song S; Ayon RJ; Yuan JX
    Cardiovasc Res; 2016 Jul; 111(1):13-5. PubMed ID: 27229459
    [No Abstract]   [Full Text] [Related]  

  • 34. Dysregulation of the gain of CICR through ryanodine receptor1 (RyR1): the putative mechanism underlying malignant hyperthermia.
    Ogawa Y
    Adv Exp Med Biol; 2007; 592():287-94. PubMed ID: 17278373
    [No Abstract]   [Full Text] [Related]  

  • 35. Does the voltage-gated calcium channel alpha2delta-1 subunit play a dual function in skeletal muscle?
    Weiss N; Ivanova E
    J Physiol; 2008 Apr; 586(8):2035-7. PubMed ID: 18292126
    [No Abstract]   [Full Text] [Related]  

  • 36. [Role of intracellular free calcium in malignant hyperthermia].
    Aquaron R
    Therapie; 1984; 39(1):29-37. PubMed ID: 6379979
    [No Abstract]   [Full Text] [Related]  

  • 37. Malignant hyperthermia: skeletal muscle defect(s) predisposing to labile Ca2+ regulation?
    Nelson TE; Butler IJ
    J Child Neurol; 1992 Oct; 7(4):329-31. PubMed ID: 1334985
    [No Abstract]   [Full Text] [Related]  

  • 38. Malignant hyperpyrexia.
    Foster PS
    Int J Biochem; 1990; 22(11):1217-22. PubMed ID: 2175272
    [No Abstract]   [Full Text] [Related]  

  • 39. Calmodulin lobotomized: novel insights into calcium regulation of voltage-gated calcium channels.
    Zamponi GW
    Neuron; 2003 Sep; 39(6):879-81. PubMed ID: 12971887
    [No Abstract]   [Full Text] [Related]  

  • 40. Dynamics of excitable elements with time-delayed coupling.
    RĂ¼diger S; Schimansky-Geier L
    J Theor Biol; 2009 Jul; 259(1):96-100. PubMed ID: 19480052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.